709 related articles for article (PubMed ID: 27570560)
1. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.
Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W
Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560
[TBL] [Abstract][Full Text] [Related]
2. ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors.
Hernandez R; Sun H; England CG; Valdovinos HF; Barnhart TE; Yang Y; Cai W
Mol Pharm; 2016 Jul; 13(7):2563-70. PubMed ID: 27280694
[TBL] [Abstract][Full Text] [Related]
3. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.
England CG; Jiang D; Hernandez R; Sun H; Valdovinos HF; Ehlerding EB; Engle JW; Yang Y; Huang P; Cai W
Mol Pharm; 2017 Oct; 14(10):3239-3247. PubMed ID: 28825843
[TBL] [Abstract][Full Text] [Related]
4. ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer.
Sun H; England CG; Hernandez R; Graves SA; Majewski RL; Kamkaew A; Jiang D; Barnhart TE; Yang Y; Cai W
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2169-2179. PubMed ID: 27342417
[TBL] [Abstract][Full Text] [Related]
5. Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas.
Yang Y; Hernandez R; Rao J; Yin L; Qu Y; Wu J; England CG; Graves SA; Lewis CM; Wang P; Meyerand ME; Nickles RJ; Bian XW; Cai W
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6525-34. PubMed ID: 26553993
[TBL] [Abstract][Full Text] [Related]
6. Bio-functionalized dense-silica nanoparticles for MR/NIRF imaging of CD146 in gastric cancer.
Wang P; Qu Y; Li C; Yin L; Shen C; Chen W; Yang S; Bian X; Fang D
Int J Nanomedicine; 2015; 10():749-63. PubMed ID: 25653520
[TBL] [Abstract][Full Text] [Related]
7. ImmunoPET imaging of tissue factor expression in pancreatic cancer with
Hernandez R; England CG; Yang Y; Valdovinos HF; Liu B; Wong HC; Barnhart TE; Cai W
J Control Release; 2017 Oct; 264():160-168. PubMed ID: 28843831
[TBL] [Abstract][Full Text] [Related]
8. NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye.
Zhang C; Zhao Y; Zhao N; Tan D; Zhang H; Chen X; Zhang H; An J; Shi C; Li M
Contrast Media Mol Imaging; 2018; 2018():4979746. PubMed ID: 29706843
[TBL] [Abstract][Full Text] [Related]
9. ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment.
Luo H; England CG; Goel S; Graves SA; Ai F; Liu B; Theuer CP; Wong HC; Nickles RJ; Cai W
Mol Pharm; 2017 May; 14(5):1646-1655. PubMed ID: 28292180
[TBL] [Abstract][Full Text] [Related]
10. ImmunoPET of CD146 in a Murine Hindlimb Ischemia Model.
Ferreira CA; Hernandez R; Yang Y; Valdovinos HF; Engle JW; Cai W
Mol Pharm; 2018 Aug; 15(8):3434-3441. PubMed ID: 29889530
[TBL] [Abstract][Full Text] [Related]
11. ImmunoPET of CD146 in Orthotopic and Metastatic Breast Cancer Models.
Li C; Kang L; Fan K; Ferreira CA; Becker KV; Huo N; Liu H; Yang Y; Engle JW; Wang R; Xu X; Jiang D; Cai W
Bioconjug Chem; 2021 Jul; 32(7):1306-1314. PubMed ID: 33475350
[TBL] [Abstract][Full Text] [Related]
12. Glypican-3-targeted 89Zr PET imaging of hepatocellular carcinoma.
Sham JG; Kievit FM; Grierson JR; Miyaoka RS; Yeh MM; Zhang M; Yeung RS; Minoshima S; Park JO
J Nucl Med; 2014 May; 55(5):799-804. PubMed ID: 24627434
[TBL] [Abstract][Full Text] [Related]
13. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.
Houghton JL; Zeglis BM; Abdel-Atti D; Aggeler R; Sawada R; Agnew BJ; Scholz WW; Lewis JS
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15850-5. PubMed ID: 26668398
[TBL] [Abstract][Full Text] [Related]
14. ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer.
England CG; Kamkaew A; Im HJ; Valdovinos HF; Sun H; Hernandez R; Cho SY; Dunphy EJ; Lee DS; Barnhart TE; Cai W
Mol Pharm; 2016 Jun; 13(6):1958-66. PubMed ID: 27054683
[TBL] [Abstract][Full Text] [Related]
15. Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinoma.
Sham JG; Kievit FM; Grierson JR; Chiarelli PA; Miyaoka RS; Zhang M; Yeung RS; Minoshima S; Park JO
J Nucl Med; 2014 Dec; 55(12):2032-7. PubMed ID: 25359880
[TBL] [Abstract][Full Text] [Related]
16. Dual-Modality ImmunoPET/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody.
Tsai WK; Zettlitz KA; Tavaré R; Kobayashi N; Reiter RE; Wu AM
Theranostics; 2018; 8(21):5903-5914. PubMed ID: 30613270
[TBL] [Abstract][Full Text] [Related]
17. ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with (89)Zr and IRDye 800CW.
Zhang Y; Hong H; Severin GW; Engle JW; Yang Y; Goel S; Nathanson AJ; Liu G; Nickles RJ; Leigh BR; Barnhart TE; Cai W
Am J Transl Res; 2012; 4(3):333-46. PubMed ID: 22937210
[TBL] [Abstract][Full Text] [Related]
18. CD146-Targeted Multimodal Image-Guided Photoimmunotherapy of Melanoma.
Wei W; Jiang D; Ehlerding EB; Barnhart TE; Yang Y; Engle JW; Luo QY; Huang P; Cai W
Adv Sci (Weinh); 2019 May; 6(9):1801237. PubMed ID: 31065511
[TBL] [Abstract][Full Text] [Related]
19. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
[TBL] [Abstract][Full Text] [Related]
20. ImmunoPET of the differential expression of CD146 in breast cancer.
Ferreira CA; Kang L; Li C; Kamkaew A; Barrett KE; Aluicio-Sarduy E; Yang Y; Engle JW; Jiang D; Cai W
Am J Cancer Res; 2021; 11(4):1586-1599. PubMed ID: 33948375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]